Press Releases
Midlands Medictech company Medherant in partnership to develop multiple new products with tech developed at University of Warwick
Midlands Medictech company Medherant has just this month (May 2020) signed a partnership agreement with Cambridge based Cycle Pharmaceuticals to develop multiple new products using Medherant technology developed by University of Warwick chemistry researchers. Coventry based Medherant’s TEPI Patch® Technology uses transdermal delivery technology (a patch that can simply be applied to the skin) and medicines for rare diseases combine to deliver significant quality-of-life benefits for patients.
A new understanding of everyday cellular processes
We use cells to breathe, to moderate body temperature, to grow and many other every day processes, however the cells in these processes are so complex its left scientists perplexed into how they develop in different environments. Researchers from the University of Warwick say future research needs to look into the bioelectrical composition of cells for answers.
The UK Public want the NHS to be the controlling body in Covid-19 contact-tracing app – says new research
The public have massive trust in the NHS, with over half (57.4%) of participants in the study favouring prioritising controlling the pandemic over privacy, they also argue the NHS should have control and access to data in the Covid-19 contact-tracing app, new research by researchers in WMG at the University of Warwick, and at the University of Birmingham have found.
DIY solution to reagent bottleneck in COVID-19 testing could also enhance future tests
Researchers in Warwick Medical School at the University of Warwick have developed a way to create more crucial reagents for use in COVID-19 tests that could also provide enhancements to the use of, and production of, future tests.
Work begins on autonomous vehicle trial route
Work has begun on the 300km Midlands Future Mobility test environment - spanning from Coventry to Birmingham, which will see autonomous vehicles trialled on urban, rural, suburban and highway roads. The project is run by a consortium of companies including WMG, MIRA, Transport for West Midlands, Costain, Amey, Wireless Infrastructure Group, Vodafone, Coventry University and Highways England.
Increased risk of heart disease, high blood pressure and type two diabetes later in life for child abuse survivors, new study finds
People who have experienced maltreatment during childhood are significantly more likely to develop conditions such as heart disease, high blood pressure and type two diabetes in adulthood, a new UK study has found.